U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06937515) titled 'MELASYL EFFICACY UNDER PART OF VISIBLE LIGHT' on April 20.
Brief Summary: The study intends to evaluate the efficacy of an anti-melanogenesis active in different concentrations under part of visible Light [400-450nm] exposures and under full visible light [400-700nm] exposures.
It is carried out on cosmetic products for which the safety has been assured by a toxicologist, with the aim of confirming the efficacy of the products, which will be used by a large number of consumers under normal and reasonably foreseeable use conditions.
Study Start Date: March 27, 2023
Study Type: OBSERVATIONAL
Condition:
Visible Light Exposure on ...